AMWL icon

American Well

8.04 USD
-0.29
3.48%
At close Mar 10, 4:00 PM EDT
1 day
-3.48%
5 days
-3.48%
1 month
-29.66%
3 months
-15.99%
6 months
0.12%
Year to date
14.20%
1 year
-59.80%
5 years
-98.26%
10 years
-98.26%
 

About: American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.

Employees: 877

0
Funds holding %
of 7,363 funds
0
Analysts bullish %
of 4 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

22% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 9

3% more funds holding

Funds holding: 62 [Q3] → 64 (+2) [Q4]

0.26% less ownership

Funds ownership: 48.97% [Q3] → 48.71% (-0.26%) [Q4]

19% less call options, than puts

Call options by funds: $231K | Put options by funds: $285K

26% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 23

27% less capital invested

Capital invested by funds: $65.8M [Q3] → $48.3M (-$17.5M) [Q4]

33% less funds holding in top 10

Funds holding in top 10: 3 [Q3] → 2 (-1) [Q4]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$10
24%
upside
Avg. target
$11.88
48%
upside
High target
$15
87%
upside

4 analyst ratings

positive
25%
neutral
75%
negative
0%
Truist Securities
Jailendra Singh
30% 1-year accuracy
10 / 33 met price target
49%upside
$12
Hold
Maintained
14 Feb 2025
Stifel
David Grossman
41% 1-year accuracy
9 / 22 met price target
24%upside
$10
Hold
Maintained
13 Feb 2025
Wells Fargo
Stan Berenshteyn
30% 1-year accuracy
3 / 10 met price target
87%upside
$15
Overweight
Upgraded
13 Jan 2025
Morgan Stanley
Craig Hettenbach
43% 1-year accuracy
3 / 7 met price target
31%upside
$10.50
Equal-Weight
Maintained
17 Dec 2024

Financial journalist opinion

Based on 9 articles about AMWL published over the past 30 days

Neutral
GlobeNewsWire
1 week ago
Amwell makes inducement grant
BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in technology-enabled care, today announced that, on March 3, 2025, it made a grant of restricted stock units (“RSUs”) covering 220,844 shares of its Class A common stock to Dan Zamansky. The grant was offered as material inducement to Zamansky's employment as Amwell's chief product and technology officer.
Amwell makes inducement grant
Neutral
GlobeNewsWire
1 week ago
Amwell announces innovation leader as chief product and technology officer
BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in technology-enabled care, announced Dan Zamansky, an industry leader in innovation and technology, as the company's new chief product and technology officer, effective today. Zamansky will lead the company's product and R&D organizations.
Amwell announces innovation leader as chief product and technology officer
Neutral
GlobeNewsWire
2 weeks ago
Amwell® makes grants to new employees under inducement plan
BOSTON, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Amwell ®  (NYSE: AMWL), a leading technology-enabled care platform provider, announced that on Feb. 18, Amwell made grants of RSUs covering an aggregate of 16,737 shares of its Class A common stock to four new employees. The grants were offered as material inducement to the employees' employment with Amwell.
Amwell® makes grants to new employees under inducement plan
Neutral
GlobeNewsWire
2 weeks ago
Amwell® to participate in upcoming investor conference
BOSTON, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, will participate in an upcoming investor conference. Ido Schoenberg, M.D.
Amwell® to participate in upcoming investor conference
Neutral
Seeking Alpha
3 weeks ago
American Well Corporation (AMWL) Q4 2024 Earnings Call Transcript
American Well Corporation (NYSE:AMWL ) Q4 2024 Earnings Conference Call February 12, 2025 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Executive Officer Mark Hirschhorn - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Stan Berenshteyn - Wells Fargo Securities Jailendra Singh - Truist Securities Eric Percher - Nephron Research Charles Rhyee - TD Cowen Matt Shea - Needham & Company Kevin Caliendo - UBS David Larsen - BTIG Jessica Tassan - Piper Sandler Operator Thank you for standing by and welcome to Amwell's Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
American Well Corporation (AMWL) Q4 2024 Earnings Call Transcript
Positive
Zacks Investment Research
3 weeks ago
Compared to Estimates, American Well (AMWL) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for American Well (AMWL) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Compared to Estimates, American Well (AMWL) Q4 Earnings: A Look at Key Metrics
Negative
Zacks Investment Research
3 weeks ago
American Well Corporation (AMWL) Reports Q4 Loss, Tops Revenue Estimates
American Well Corporation (AMWL) came out with a quarterly loss of $2.77 per share versus the Zacks Consensus Estimate of a loss of $2.82. This compares to loss of $3.40 per share a year ago.
American Well Corporation (AMWL) Reports Q4 Loss, Tops Revenue Estimates
Neutral
GlobeNewsWire
3 weeks ago
Amwell® Announces Results for Fourth Quarter and Full Year 2024
BOSTON, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the fourth quarter and full year ended Dec. 31, 2024. Visit Amwell's investor relations website at investors.amwell.com to view the fourth quarter and full year 2024 earnings report.
Amwell® Announces Results for Fourth Quarter and Full Year 2024
Neutral
Zacks Investment Research
3 weeks ago
American Well (AMWL) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Get a deeper insight into the potential performance of American Well (AMWL) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
American Well (AMWL) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Neutral
GlobeNewsWire
1 month ago
Amwell® to report fourth quarter and full year 2024 operating results
BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, will report fourth quarter 2024 operating results after stock market trading hours on Wednesday, Feb. 12.
Amwell® to report fourth quarter and full year 2024 operating results
Charts implemented using Lightweight Charts™